Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Shahin Jamal"'
Autor:
Glen S. Hazlewood, Jordi Pardo Pardo, Cheryl Barnabe, Orit Schieir, Claire E.H. Barber, Laurie Proulx, Dawn P. Richards, Peter Tugwell, Nick Bansback, Pooneh Akhavan, Claire Bombardier, Vivian Bykerk, Shahin Jamal, Majed Khraishi, Regina Taylor-Gjevre, J. Carter Thorne, Arnav Agarwal, Janet E. Pope
Publikováno v:
The Journal of rheumatology. 49(10)
ObjectiveTo provide the initial installment of a living guideline that will provide up-to-date guidance on the pharmacological management of patients with rheumatoid arthritis (RA) in Canada.MethodsThe Canadian Rheumatology Association (CRA) formed a
Autor:
Susan M. Goodman, Shahin Jamal, Carol A. Hitchon, Kathleen M. Andersen, Diane Tin, Catch Investigators, Vivian P. Bykerk, Susan J. Bartlett, Boulos Haraoui, Carter Thorne, Orit Schieir, Elizabeth Schulman, Janet E. Pope, Edward C. Keystone, Gilles Boire
Publikováno v:
Arthritis Care & Research. 70:1185-1191
OBJECTIVE Obesity is implicated in rheumatoid arthritis (RA) development, severity, outcomes, and treatment response. We estimated the independent effects of overweight and obesity on ability to achieve sustained remission (sREM) in the 3 years follo
Autor:
D. Lin, Edward C. Keystone, Shahin Jamal, J. Carter Thorne, Janet E. Pope, Diane Tin, Gilles Boire, Vivian P. Bykerk, Glen Hazlewood, Carol A. Hitchon, Boulos Haraoui
Publikováno v:
Annals of the Rheumatic Diseases. 75:1003-1008
ObjectiveTo determine the comparative effectiveness of oral versus subcutaneous methotrexate (MTX) as initial therapy for patients with early rheumatoid arthritis (ERA).MethodsPatients with ERA (symptoms ≤1 year) initiating MTX therapy were include
Autor:
Bindee, Kuriya, Orit, Schieir, Daming, Lin, Juan, Xiong, Janet, Pope, Gilles, Boire, Boulos, Haraoui, John Carter, Thorne, Diane, Tin, Carol, Hitchon, Shahin, Jamal, Edward, Keystone, Vivien P, Bykerk
Publikováno v:
Clinical and experimental rheumatology. 35(5)
The 28-Joint Disease Activity Score (DAS28) using C-reactive protein (CRP) and DAS28 using erythrocyte sedimentation rate (DAS28-ESR) may not be interchangeable. We sought to compare and estimate optimal thresholds for the DA28-CRP for use in early r
Publikováno v:
The Journal of Rheumatology. 38:1282-1288
Objective.To determine the proportion of patients with rheumatoid arthritis (RA) seen by rheumatologists and treated with disease-modifying antirheumatic drugs (DMARD) within 3 months of symptom onset, to determine where treatment delays occur, and t
Publikováno v:
Clinical Rheumatology. 28:413-419
In recent years, there has been a shift in the therapeutic approach to rheumatoid arthritis (RA), with emphasis on early therapy. The DE019 trial demonstrated adalimumab efficacy in patients with RA. This subanalysis compares response to adalimumab b
Autor:
J. Carter Thorne, Diane Tin, Boulos Haraoui, Catch Investigators, Shahin Jamal, Carol A. Hitchon, Jeffrey R. Curtis, Cheryl Barnabe, Edward C. Keystone, Désirée van der Heijde, Susan J. Bartlett, Janet E. Pope, Gilles Boire, Ye Sun, Vivian P. Bykerk
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 8, p e0135327 (2015)
PLoS ONE, Vol 10, Iss 8, p e0135327 (2015)
Our objective was to identify distinct trajectories of disease activity state (DAS) and assess variation in radiographic progression, function and quality of life over the first two years of early rheumatoid arthritis (ERA). The CATCH (Canadian early
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ee41bb0602ff1f178ccc70706cb5d5f
https://hdl.handle.net/1887/100334
https://hdl.handle.net/1887/100334
Autor:
Diane Tin, Carter Thorne, E.C. Keystone, Janet E. Pope, Shahin Jamal, Carol A. Hitchon, Gilles Boire, Vivian P. Bykerk, Boulos Haraoui
Publikováno v:
Rheumatology (Oxford, England). 55(10)
OBJECTIVE Comorbid medical conditions may influence treatment and contribute to poor outcomes in early RA. We aimed to assess the association of baseline comorbidity with outcomes in early inflammatory arthritis using data from the Canadian Early Art
Autor:
Cheryl Barnabe, Robert Offer, Anthony S. Russell, Kam Shojania, Boulos Haraoui, Vandana Ahluwalla, Wojciech P. Olszynski, Shahin Jamal
Publikováno v:
Clinical rheumatology. 31(9)
We have reviewed the issues surrounding the advent of biosimilars in the rheumatoid arthritis biologic field. Our proposals emphasize the need to focus primarily on patient safety and to assess the outcomes of therapy both in the short and longer ter